Galecto, Inc. - Common Stock (NQ:GLTO)

28.69 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galecto, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

The trading volume of these stocks is deviating from the norm in today's session. ↗

February 13, 2026

Via Chartmill

These stocks have an unusual volume in today's session ↗

February 12, 2026

Via Chartmill

Wednesday's pre-market session: top gainers and losers ↗

November 26, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 13, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

November 11, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

November 11, 2025

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 11, 2025

Via Benzinga

Galecto Stock Surges Premarket After Damora Acquisition — Retail Bulls Predict Another Massive Rally ↗

November 11, 2025

Galecto announced the acquisition of Damora Therapeutics and a $285 million private raise backed by major biotech investors, including Viking Global, RA Capital, and a16z Bio + Health.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results ↗

November 10, 2025

Via Benzinga

Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029 ↗

November 10, 2025

Galecto stock jumps after acquiring Damora Therapeutics and raising $285 million to advance blood cancer programs through 2029.

Via Benzinga

S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings ↗

November 10, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges ↗

October 10, 2025

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Via Benzinga

These stocks are moving in today's session ↗

October 09, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 09, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

October 09, 2025

Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings ↗

October 09, 2025

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs....

Via Benzinga

Gapping stocks in Thursday's session ↗

October 09, 2025

The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

October 08, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 08, 2025

Via Benzinga

Top movers in Wednesday's session ↗

October 08, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

October 08, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗

October 08, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

October 08, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

October 08, 2025

Via Benzinga

POET Technologies, Oracle, Nuburu, Galecto And TMC The Metals Company: Why These 5 Stocks Are On Investors' Radars Today ↗

October 07, 2025

On Tuesday, major U.S. indices closed lower, with the Dow Jones Industrial Average slipping 0.2% to 46,602.98, the S&P 500 falling nearly 0.4% to 6,714.59.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.